LENOGRASTIM: 740 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Route: ORAL · Manufacturer: Guna spa · HUMAN OTC DRUG · FDA Label: Available
First Report: 19960612 · Latest Report: 20250802
What Are the Most Common LENOGRASTIM Side Effects?
All LENOGRASTIM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pyrexia | 95 | 12.8% | 8 | 72 |
| Vomiting | 61 | 8.2% | 4 | 53 |
| Neutropenia | 59 | 8.0% | 3 | 51 |
| Dyspnoea | 55 | 7.4% | 1 | 50 |
| Fatigue | 55 | 7.4% | 15 | 51 |
| Nausea | 53 | 7.2% | 0 | 44 |
| Pneumonia | 51 | 6.9% | 11 | 43 |
| Arthralgia | 50 | 6.8% | 0 | 49 |
| Febrile neutropenia | 50 | 6.8% | 5 | 35 |
| Off label use | 50 | 6.8% | 9 | 20 |
| Urinary tract infection | 49 | 6.6% | 0 | 49 |
| Headache | 47 | 6.4% | 0 | 46 |
| Dysphagia | 45 | 6.1% | 10 | 45 |
| Rash maculo-papular | 45 | 6.1% | 0 | 19 |
| Bone pain | 44 | 6.0% | 0 | 42 |
| Loss of consciousness | 42 | 5.7% | 6 | 41 |
| Pain | 42 | 5.7% | 5 | 41 |
| Sepsis | 42 | 5.7% | 2 | 29 |
| Lung disorder | 41 | 5.5% | 4 | 41 |
| General physical health deterioration | 40 | 5.4% | 3 | 39 |
Who Reports LENOGRASTIM Side Effects? Age & Gender Data
Gender: 58.8% female, 41.2% male. Average age: 44.6 years. Most reports from: FR. View detailed demographics →
Is LENOGRASTIM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 0 |
| 2004 | 2 | 2 | 0 |
| 2005 | 1 | 0 | 0 |
| 2006 | 11 | 8 | 7 |
| 2007 | 1 | 0 | 0 |
| 2009 | 8 | 0 | 7 |
| 2011 | 2 | 1 | 1 |
| 2012 | 5 | 1 | 3 |
| 2013 | 15 | 4 | 12 |
| 2014 | 58 | 3 | 39 |
| 2015 | 70 | 6 | 55 |
| 2016 | 34 | 16 | 21 |
| 2017 | 37 | 0 | 17 |
| 2018 | 62 | 6 | 47 |
| 2019 | 56 | 1 | 51 |
| 2020 | 60 | 3 | 40 |
| 2021 | 26 | 3 | 14 |
| 2022 | 25 | 1 | 17 |
| 2023 | 46 | 8 | 20 |
| 2024 | 31 | 5 | 21 |
| 2025 | 15 | 8 | 7 |
What Is LENOGRASTIM Used For?
| Indication | Reports |
|---|---|
| Neutropenia | 174 |
| Product used for unknown indication | 117 |
| Prophylaxis | 51 |
| B-cell lymphoma | 46 |
| Plasma cell myeloma | 35 |
| Acute lymphocytic leukaemia | 25 |
| Haematopoietic stem cell mobilisation | 22 |
| Aplasia | 21 |
| Germ cell cancer metastatic | 21 |
| Neutrophil count decreased | 18 |
LENOGRASTIM vs Alternatives: Which Is Safer?
Official FDA Label for LENOGRASTIM
Official prescribing information from the FDA-approved drug label.
FDA Approved Uses (Indications)
INDICATIONS & USAGE IMMUNE SUPPORT
Dosage & Administration
DIRECTIONS Take 15 minutes before meals. Adults and children 12 years and older 20 drops twice a day in a little water. Hold in the mouth for about 30 seconds then swallow. Children between 12 years and 6 years of age 10 drops twice a day in a little water. Hold in the mouth for about 30 seconds then swallow. Children under 6 years 5 drops twice a day in a glass of water.
Warnings
WARNINGS Stop use and ask doctor if symptoms worsen or persist more than 5 days
Active Ingredient
ACTIVE INGREDIENT GRANULOCYTE COLONY STIMULATING FACTOR 4C
Inactive Ingredients
INACTIVE INGREDIENT Ethyl Alcohol 30%